• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价用于控制医疗体系中消费者道德风险的策略。

A systematic review of strategies used for controlling consumer moral hazard in health systems.

机构信息

Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Health Serv Res. 2022 Oct 18;22(1):1260. doi: 10.1186/s12913-022-08613-y.

DOI:10.1186/s12913-022-08613-y
PMID:36258192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9580205/
Abstract

BACKGROUND

Consumer moral hazard refers to an increase in demand for health services or a decrease in preventive care due to insurance coverage. This phenomenon as one of the most evident forms of moral hazard must be reduced and prevented because of its important role in increasing health costs. This study aimed to determine and analyze the strategies used to control consumer moral hazards in health systems.

METHODS

In this systematic review. Web of Sciences, PubMed, Scopus, Embase, ProQuest, Iranian databases(Magiran and SID), and Google Scholar engine were searched using search terms related to moral hazard and healthcare utilization without time limitation. Eligible English and Persian studies on consumer moral hazard in health were included, and papers outside the health and in other languages were excluded. Thematic content analysis was used for data analysis.

RESULTS

Content analysis of 68 studies included in the study was presented in the form of two group, six themes, and 11 categories. Two group included "changing behavior at the time of receiving health services" and "changing behavior before needing health services." The first group included four themes: demand-side cost sharing, health savings accounts, drug price regulation, and rationing of health services. The second approach consisted of two themes Development of incentive insurance programs and community empowerment.

CONCLUSION

Strategies to control consumer moral hazards focus on changing consumer consumptive and health-related behaviors, which are designed according to the structure of health and financing systems. Since "changing consumptive behavior" strategies are the most commonly used strategies; therefore, it is necessary to strengthen strategies to control health-related behaviors and develop new strategies in future studies. In addition, in the application of existing strategies, the adaptation to the structure of the health and financing system, and the pattern of consumption of health services in society should be considered.

摘要

背景

消费者道德风险是指由于保险覆盖而导致对医疗服务需求的增加或预防性护理的减少。这种道德风险最明显的形式之一,必须加以减少和防范,因为它在增加医疗费用方面起着重要作用。本研究旨在确定和分析用于控制医疗保健系统中消费者道德风险的策略。

方法

在这项系统评价中,我们无时间限制地使用与道德风险和医疗保健利用相关的搜索词,在 Web of Sciences、PubMed、Scopus、Embase、ProQuest、伊朗数据库(Magiran 和 SID)和 Google Scholar 引擎上进行了搜索。纳入了有关医疗保健中消费者道德风险的英文和波斯语合格研究,排除了非医疗保健和其他语言的论文。采用主题内容分析法进行数据分析。

结果

对纳入研究的 68 项研究进行内容分析,以两组、六个主题和 11 个类别呈现。两组包括“在接受医疗服务时改变行为”和“在需要医疗服务之前改变行为”。第一组包括四个主题:需求方成本分担、健康储蓄账户、药品价格管制和医疗服务配给。第二种方法包括两个主题:激励保险计划的发展和社区赋权。

结论

控制消费者道德风险的策略侧重于改变消费者的消费和与健康相关的行为,这些策略是根据卫生和融资系统的结构设计的。由于“改变消费行为”策略是最常用的策略;因此,在未来的研究中,有必要加强控制与健康相关的行为的策略,并开发新的策略。此外,在应用现有策略时,应考虑适应卫生和融资系统的结构以及社会对卫生服务的消费模式。

相似文献

1
A systematic review of strategies used for controlling consumer moral hazard in health systems.系统评价用于控制医疗体系中消费者道德风险的策略。
BMC Health Serv Res. 2022 Oct 18;22(1):1260. doi: 10.1186/s12913-022-08613-y.
2
Demand-side Interventions to Control Moral Hazard in Health Systems, Beneficial or Detrimental: A Systematic Review Study.控制卫生系统中道德风险的需求侧干预措施:有益还是有害?一项系统评价研究
Med J Islam Repub Iran. 2022 Jun 27;36:69. doi: 10.47176/mjiri.36.69. eCollection 2022.
3
Moral hazard and consumer-driven health care: a fundamentally flawed concept.道德风险与消费者主导的医疗保健:一个存在根本缺陷的概念。
Int J Health Serv. 2007;37(2):333-51. doi: 10.2190/J354-150M-NG76-7340.
4
The moral hazard effects of consumer responses to targeted cost-sharing.消费者对有针对性的成本分担做出反应的道德风险效应。
J Health Econ. 2017 Dec;56:201-221. doi: 10.1016/j.jhealeco.2017.09.012. Epub 2017 Oct 12.
5
Demand-side financing measures to increase maternal health service utilisation and improve health outcomes: a systematic review of evidence from low- and middle-income countries.增加孕产妇保健服务利用率并改善健康结果的需求侧融资措施:对低收入和中等收入国家证据的系统评价
JBI Libr Syst Rev. 2012;10(58):4165-4567. doi: 10.11124/jbisrir-2012-408.
6
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
7
How do moral hazard behaviors lead to the waste of medical insurance funds? An empirical study from China.道德风险行为如何导致医疗保险基金浪费?来自中国的实证研究。
Front Public Health. 2022 Oct 26;10:988492. doi: 10.3389/fpubh.2022.988492. eCollection 2022.
8
Which moral hazard? Health care reform under the Affordable Care Act of 2010.哪种道德风险?2010年《平价医疗法案》下的医疗保健改革。
J Health Organ Manag. 2016 Jun 20;30(4):510-29. doi: 10.1108/JHOM-03-2015-0054.
9
Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.创新与保险覆盖范围对处方药需求价格弹性的影响:药物经济学中的一些实证教训
J Med Econ. 2020 Sep;23(9):915-922. doi: 10.1080/13696998.2020.1772797. Epub 2020 Jun 25.
10
Asymmetric Information in Iranian's Health Insurance Market: Testing of Adverse Selection and Moral Hazard.伊朗健康保险市场中的信息不对称:逆向选择与道德风险的检验
Glob J Health Sci. 2015 Apr 19;7(6):146-55. doi: 10.5539/gjhs.v7n6p146.

引用本文的文献

1
Incentives in prescribing, dispensing and pharmaceutical spending: A scientometric mapping.处方、配药及药品支出方面的激励措施:一项科学计量映射研究。
F1000Res. 2025 Feb 11;13:1333. doi: 10.12688/f1000research.156306.1. eCollection 2024.
2
The Impact of Moral Hazard on Healthcare Utilization in Public Hospitals from Romania: Evidence from Patient Behaviors and Insurance Systems.道德风险对罗马尼亚公立医院医疗服务利用的影响:来自患者行为和保险系统的证据。
Healthcare (Basel). 2024 Dec 12;12(24):2519. doi: 10.3390/healthcare12242519.

本文引用的文献

1
Paying for pharmaceuticals: uniform pricing versus two-part tariffs.药品付费:统一定价与两部收费制。
J Health Econ. 2022 May;83:102613. doi: 10.1016/j.jhealeco.2022.102613. Epub 2022 Mar 19.
2
Can risk rating increase the ability of voluntary deductibles to reduce moral hazard?风险评级能否提高自愿免赔额降低道德风险的能力?
Geneva Pap Risk Insur Issues Pract. 2023;48(1):130-156. doi: 10.1057/s41288-021-00253-3. Epub 2021 Nov 2.
3
Common patterns in the public reporting of waiting time and waiting list information: Findings from a sample of OECD jurisdictions.
OECD 司法管辖区等待时间和等待名单信息公开报告的常见模式:抽样调查结果。
Health Policy. 2021 Aug;125(8):1002-1012. doi: 10.1016/j.healthpol.2021.05.013. Epub 2021 Jun 23.
4
Drawbacks and aftermath of the Affordable Care Act: ex-ante moral hazard and inequalities in health care access.《平价医疗法案》的弊端与后果:事前道德风险与医疗保健获取方面的不平等
J Public Health Res. 2021 May 5;10(4):2135. doi: 10.4081/jphr.2021.2135.
5
Cost sharing and the demand for health services in a regulated market.在有管制的市场中,费用分担与卫生服务需求。
Health Econ. 2021 Jun;30(6):1259-1275. doi: 10.1002/hec.4244. Epub 2021 Mar 17.
6
Health care insurance policies When the provider and patient may collude.医疗保险政策,当提供者和患者可能勾结时。
Health Econ. 2021 Mar;30(3):525-543. doi: 10.1002/hec.4206. Epub 2020 Dec 17.
7
Deductibles in Health Insurance, Beneficial or Detrimental: A Review Article.医疗保险中的免赔额:有益还是有害?一篇综述文章
Iran J Public Health. 2020 May;49(5):851-859.
8
Moral hazard and selection for voluntary deductibles.道德风险与自愿免赔额选择。
Health Econ. 2020 Oct;29(10):1251-1269. doi: 10.1002/hec.4134. Epub 2020 Jul 31.
9
Incentivizing efficient utilization without reducing access: The case against cost-sharing in insurance.在不减少医疗服务可及性的前提下激励高效利用:反对保险中成本分摊的案例。
Health Econ. 2020 Jul;29(7):827-840. doi: 10.1002/hec.4023. Epub 2020 Apr 22.
10
Out of pocket or out of control: A qualitative analysis of healthcare professional stakeholder involvement in pharmaceutical policy change in Ireland.自掏腰包还是失控:爱尔兰医疗保健专业利益相关者参与药品政策变革的定性分析。
Health Policy. 2020 Apr;124(4):411-418. doi: 10.1016/j.healthpol.2020.02.011. Epub 2020 Feb 28.